Skip to main content
. Author manuscript; available in PMC: 2014 Dec 2.
Published in final edited form as: Am J Hematol. 2011 Jan;86(1):92–95. doi: 10.1002/ajh.21896

Table 2.

Comparison between TLC SF-36 Scores and US norms

SF-36 measure US norm TLC (n=264) p-value* Effect size# US patients only p-value Effect size#
Physical Functioning 50 48.18* 0.004 0.18 49.32 0.35 0.068
Role-Physical 50 47.33* <0.0001 0.27 (small) 48.52* 0.042 0.15
Bodily Pain 50 49.41 0.35 0.059 50.19 0.80 −0.019
General Health 50 41.5* <0.0001 0.85 (large) 41.27* <0.0001 0.87 (large)
Vitality 50 48.89 0.08 0.11 49.65 0.63 0.035
Social Functioning 50 46.79* <0.0001 0.32 (small) 48.01* 0.006 0.20
Role-Emotional 50 46.78* <0.0001 0.32 (small) 48.15* 0.01 0.18
Mental Health 50 49.04 0.12 0.096 49.38 0.40 0.062
Physical Summary 50 46.8* <0.0001 0.32 (small) 47.57* <0.0001 0.24 (small)
Mental Summary 50 47.95* 0.002 0.20 48.73 0.11 0.13
*

one sample T test shows significant difference between population and US norm (p<0.05)

#

effect size = difference in mean / population SD

Clinically significant effects defined as: 0.2-0.49 = ‘small’, 0.50-0.79 = ‘moderate’, >0.80 = ‘large’(8)